Table of Contents Author Guidelines Submit a Manuscript
AIDS Research and Treatment
Volume 2017, Article ID 5415298, 10 pages
https://doi.org/10.1155/2017/5415298
Review Article

Mortality and Its Predictors among HIV Infected Patients Taking Antiretroviral Treatment in Ethiopia: A Systematic Review

Department of Clinical Pharmacy, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia

Correspondence should be addressed to Mohammed Biset Ayalew; moc.liamg@7676bm

Received 6 July 2017; Revised 18 September 2017; Accepted 3 October 2017; Published 30 October 2017

Academic Editor: Patrice K. Nicholas

Copyright © 2017 Mohammed Biset Ayalew. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. UNAIDS, “UNAIDS report on the global AIDS epidemic,” Tech. Rep., UNAIDS, Geneva, Switzerland, 2013. View at Google Scholar
  2. S. O. Muhula, M. Peter, B. Sibhatu, N. Meshack, and K. Lennie, “Effects of highly active antiretroviral therapy on the survival of hiv-infected adult patients in urban slums of kenya,” Pan African Medical Journal, vol. 20, no. 1, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. WHO, “Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: summary of key features and recommendations,” Tech. Rep., WHO, Geneva, Switzerland, 2013. View at Google Scholar
  4. HAPCOF, “Report on progress towards implementation of the UN declaration of commitment on HIV/AIDS,” Tech. Rep., 2010. View at Google Scholar
  5. W. B. Sapa, N. T. Negassi, and A. H. Chofore, “Survival pattern and its determinants among adult HIV-infected patients after initiation of HAART in Dilla hospital Ethiopia,” Journal of AIDS & Clinical Research, vol. 1, no. 1, pp. 1–6, 2016. View at Google Scholar
  6. I. Wanyeki, D. Cole, G. Sills, and P. Bass, Eds.“Five year survival probabilities after ART start at 3 hospitals in Guyana,” in Proceedings of the Caribbean HIV Conference, I. Wanyeki, D. Cole, G. Sills, and P. Bass, Eds., Nassau, The Bahamas, November 2011.
  7. J. Ayalew, H. Moges, and A. Worku, “Identifying factors related to the survival of AIDS patients under the follow-up of Antiretroviral Therapy (ART): the case of South Wollo,” International Journal of Data Envelopment Analysis and Operations Research, vol. 1, no. 2, pp. 21–27, 2014. View at Google Scholar
  8. T. Setegn, A. Takele, T. Gizaw, D. Nigatu, and D. Haile, “Predictors of mortality among adult antiretroviral therapy users in southeastern Ethiopia: retrospective cohort study,” AIDS Research and Treatment, vol. 2015, Article ID 148769, 8 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. P. MacPherson, M. Moshabela, N. Martinson, and P. Pronyk, “Mortality and loss to follow-up among HAART initiators in rural South Africa,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 103, no. 6, pp. 588–593, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. Z. Mulissa, D. Jerene, and B. Lindtjørn, “Patients present earlier and survival has improved, but pre-ART attrition is high in a six-year HIV cohort data from Ethiopia,” PLoS ONE, vol. 5, no. 10, Article ID e13268, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. D. Lawn, A. D. Harries, X. Anglaret, L. Myer, and R. Wood, “Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa,” AIDS, vol. 22, no. 15, pp. 1897–1908, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. I. Sieleunou, M. Souleymanou, A.-M. Schönenberger, J. Menten, and M. Boelaert, “Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon,” Tropical Medicine & International Health, vol. 14, no. 1, pp. 36–43, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Johannessen, E. Naman, B. J. Ngowi et al., “Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania,” BMC Infectious Diseases, vol. 8, no. 1, article 52, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Von Elm, G. Altman, and M. Egger, “The Strengthening the Reporting of Observational Studies in Epidemiology [STROBE] statement: guidelines for reporting observational studies,” Gaceta Sanitaria, vol. 22, no. 2, pp. 144–150, 2008. View at Publisher · View at Google Scholar
  15. J. Rubaihayo, N. M. Tumwesigye, J. Konde-Lule et al., “Trends and predictors of mortality among HIV positive patients in the era of highly active antiretroviral therapy in Uganda,” Infectious Disease Reports, vol. 7, no. 3, pp. 66–73, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Ramani Roja, P. Benu, S. H. Rao, R. M V, P. Simanchal, and K. Prasanna, “Predictors of mortality among HIV patients on HAART in an ART centre—a retrospective study,” International Journal of Medicine and Public Health, vol. 6, no. 4, pp. 175–179, 2016. View at Publisher · View at Google Scholar
  17. S. H. Lee, K.-H. Kim, S. G. Lee et al., “Causes of death and risk factors for mortality among HIV-infected patients receiving antiretroviral therapy in korea,” Journal of Korean Medical Science, vol. 28, no. 7, pp. 990–997, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. D. W. Lowrance, F. Ndamage, E. Kayirangwa et al., “Adult clinical and immunologic outcomes of the national antiretroviral treatment program in Rwanda during 2004-2005,” Journal of Acquired Immune Deficiency Syndromes, vol. 52, no. 1, pp. 49–55, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Rougemont, B. E. Stoll, N. Elia, and P. Ngang, “Antiretroviral treatment adherence and its determinants in Sub-Saharan Africa: a prospective study at Yaounde Central Hospital, Cameroon,” AIDS Research and Therapy, vol. 6, article 21, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Braitstein, M. W. Brinkhof, F. Dabis, and M. Schechter, “Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries,” The Lancet, vol. 367, no. 9513, pp. 817–824, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Bachani, R. Garg, B. B. Rewari et al., “Two-year treatment outcomes of patients enrolled in India's national first-line antiretroviral therapy programme,” National Medical Journal of India, vol. 23, no. 1, pp. 7–12, 2010. View at Google Scholar · View at Scopus
  22. N. I. Paton, S. Sangeetha, A. Earnest, and R. Bellamy, “The impact of malnutrition on survival and the CD4 count response in HIV-infected patients starting antiretroviral therapy,” HIV Medicine, vol. 7, no. 5, pp. 323–330, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Zachariah, M. Fitzgerald, M. Massaquoi et al., “Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi,” AIDS, vol. 20, no. 18, pp. 2355–2360, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. J. S. A. Stringer, I. Zulu, J. Levy et al., “Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes,” Journal of the American Medical Association, vol. 296, no. 7, pp. 782–793, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. V. Poka-Mayap, E. W. Pefura-Yone, A. P. Kengne, and C. Kuaban, “Mortality and its determinants among patients infected with HIV-1 on antiretroviral therapy in a referral centre in Yaounde, Cameroon: a retrospective cohort study,” British Medical Journal, vol. 3, no. 7, Article ID e003210, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Gupta, G. Nadkarni, W.-T. Yang et al., “Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis,” PLoS ONE, vol. 6, no. 12, Article ID e28691, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Chalamilla, C. Hawkins, J. Okuma et al., “Mortality and treatment failure among HIV-infected adults in Dar Es Salaam, Tanzania,” Journal of the International Association of Physicians in AIDS Care, vol. 11, no. 5, pp. 296–304, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Amuron, J. Levin, J. Birunghi et al., “Mortality in an antiretroviral therapy programme in Jinja, south-east Uganda: a prospective cohort study,” AIDS Research and Therapy, vol. 8, article 39, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Bhatta, E. Klouman, K. Deuba et al., “Survival on antiretroviral treatment among adult HIV-infected patients in Nepal: a retrospective cohort study in far-western Region, 2006–2011,” BMC Infectious Diseases, vol. 13, no. 1, article 604, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Mageda, G. H. Leyna, and E. J. Mmbaga, “High initial HIV/AIDS-Related mortality and—its predictors among patients on antiretroviral therapy in the kagera region of Tanzania: a five-year retrospective cohort study,” AIDS Research and Treatment, vol. 2012, Article ID 843598, 7 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. B. O. Ojikutu, H. Zheng, R. P. Walensky et al., “Predictors of mortality in patients initiating antiretroviral therapy in Durban, South Africa,” South African Medical Journal, vol. 98, no. 3, pp. 204–208, 2008. View at Google Scholar · View at Scopus
  32. G. P. Bisson, T. Gaolathe, R. Gross et al., “Overestimates of survival after HAART: implications for global scale-up efforts,” PLoS ONE, vol. 3, no. 3, Article ID e1725, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. D. D. Cuong, A. Thorson, A. Sönnerborg et al., “Survival and causes of death among HIV-infected patients starting antiretroviral therapy in north-eastern Vietnam,” Infectious Diseases, vol. 44, no. 3, pp. 201–208, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Suchindran, E. S. Brouwer, and A. Van Rie, “Is HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic review,” PLoS ONE, vol. 4, no. 5, Article ID e5561, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Ghate, S. Deshpande, S. Tripathy et al., “Mortality in HIV infected individuals in Pune, India,” Indian Journal of Medical Research, vol. 133, no. 4, pp. 414–420, 2011. View at Google Scholar · View at Scopus
  36. B. K. Kigozi, S. Sumba, P. Mudyope et al., “The effect of AIDS defining conditions on immunological recovery among patients initiating antiretroviral therapy at Joint Clinical Research Centre, Uganda,” AIDS Research and Therapy, vol. 6, article 17, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. F. A. Khan, J. Minion, M. Pai et al., “Treatment of active tuberculosis in HIV-coinfected patients: a systematic review and meta-analysis,” Clinical Infectious Diseases, vol. 50, no. 9, pp. 1288–1299, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. E. Mossdorf, M. Stoeckle, E. G. Mwaigomole et al., “Improved antiretroviral treatment outcome in a rural African setting is associated with cART initiation at higher CD4 cell counts and better general health condition,” BMC Infectious Diseases, vol. 11, article 98, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Grabar, L. Weiss, and D. Costagliola, “HIV infection in older patients in the HAART era,” Journal of Antimicrobial Chemotherapy, vol. 57, no. 1, pp. 4–7, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Kouanda, I. B. Meda, L. Nikiema et al., “Determinants and causes of mortality in HIV-infected patients receiving antiretroviral therapy in Burkina Faso: a five-year retrospective cohort study,” AIDS Care Psychological and Socio-medical Aspects of AIDS/HIV, vol. 24, no. 4, pp. 478–490, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Lubis, A. Bulgiba, A. Kamarulzaman, N. N. Hairi, M. Dahlui, and D. Peramalah, “Predictors of death in Malaysian HIV-infected patients on anti-retroviral therapy,” Preventive Medicine, vol. 57, pp. S54–S56, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. I. Jarrin, B. Lumbreras, I. Ferreros, S. Pérez-Hoyos, I. Hurtado, and I. Hernández-Aguado, “Effect of education on overall and cause-specific mortality in injecting drug users, according to HIV and introduction of HAART,” International Journal of Epidemiology, vol. 36, no. 1, pp. 187–194, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. S. I. Bello and O. A. Itiola, “Drug adherence amongst tuberculosis patients in the university of ilorin teaching hospital, ilorin, nigeria,” African Journal of Pharmacy and Pharmacology, vol. 4, no. 3, pp. 109–114, 2010. View at Google Scholar · View at Scopus
  44. K. Deribe, A. Yami, A. Deribew et al., “Predictors of mortality among tuberculosis/HIV-coinfected persons in southwest ethiopia: a case-control study,” Journal of the International Association of Providers of AIDS Care, vol. 14, no. 3, pp. 269–273, 2015. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Taylor-Smith, H. Tweya, A. Harries, E. Schoutene, and A. Jahn, “Gender differences in retention and survival on antiretroviral therapy of HIV-1 infected adults in Malawi,” Malawi Medical Journal, vol. 22, no. 2, pp. 49–56, 2010. View at Google Scholar · View at Scopus